Pregnant MS patients had a highly significant increase in the percentage and absolute cell count of CD14 positive monocytes in blood, compared to non-pregnant RRMS patients (p < 0.0001), respectively, Figures 1A, B. This evidence concerns the gene CD14 and myeloid sarcoma.